Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsBy ATAC-seq analyses of EpCAM+ pancreatic ductal adenocarcinoma malignant epithelial cells sorted from 54 freshly resected human tumors, we show here the discovery of a signature of 1092 chromatin loci displaying differential accessibility between patients with disease free survival (DFS) < 1 year and patients with DFS > 1 year.
[Nature Communications]
7753456 GPR5C4IJ items 1 apa 0 default asc 1 162574 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-9824d8604447d281c233733acbcbd4b3%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22GPR5C4IJ%22%2C%22library%22%3A%7B%22id%22%3A7753456%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Dhara%20et%20al.%22%2C%22parsedDate%22%3A%222021-05-24%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EDhara%2C%20S.%2C%20Chhangawala%2C%20S.%2C%20Chintalapudi%2C%20H.%2C%20Askan%2C%20G.%2C%20Aveson%2C%20V.%2C%20Massa%2C%20A.%20L.%2C%20Zhang%2C%20L.%2C%20Torres%2C%20D.%2C%20Makohon-Moore%2C%20A.%20P.%2C%20Lecomte%2C%20N.%2C%20Melchor%2C%20J.%20P.%2C%20Bermeo%2C%20J.%2C%20Cardenas%2C%20A.%2C%20Sinha%2C%20S.%2C%20Glassman%2C%20D.%2C%20Nicolle%2C%20R.%2C%20Moffitt%2C%20R.%2C%20Yu%2C%20K.%20H.%2C%20Leppanen%2C%20S.%2C%20%26%23x2026%3B%20Leach%2C%20S.%20D.%20%282021%29.%20Pancreatic%20cancer%20prognosis%20is%20predicted%20by%20an%20ATAC-array%20technology%20for%20assessing%20chromatin%20accessibility.%20%3Ci%3ENature%20Communications%3C%5C%2Fi%3E%2C%20%3Ci%3E12%3C%5C%2Fi%3E%281%29%2C%203044.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41467-021-23237-2%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41467-021-23237-2%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D7753456%26amp%3Bitem_key%3DGPR5C4IJ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Pancreatic%20cancer%20prognosis%20is%20predicted%20by%20an%20ATAC-array%20technology%20for%20assessing%20chromatin%20accessibility%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Dhara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Chhangawala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%22%2C%22lastName%22%3A%22Chintalapudi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Askan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Aveson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20L.%22%2C%22lastName%22%3A%22Massa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Torres%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20P.%22%2C%22lastName%22%3A%22Makohon-Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Lecomte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20P.%22%2C%22lastName%22%3A%22Melchor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Bermeo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Cardenas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Sinha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Glassman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Nicolle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Moffitt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20H.%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Leppanen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Laderman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Curry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Gui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%20P.%22%2C%22lastName%22%3A%22Balachandran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Iacobuzio-Donahue%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Chandwani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20S.%22%2C%22lastName%22%3A%22Leslie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20D.%22%2C%22lastName%22%3A%22Leach%22%7D%5D%2C%22abstractNote%22%3A%22Unlike%20other%20malignancies%2C%20therapeutic%20options%20in%20pancreatic%20ductal%20adenocarcinoma%20%28PDAC%29%20are%20largely%20limited%20to%20cytotoxic%20chemotherapy%20without%20the%20benefit%20of%20molecular%20markers%20predicting%20response.%20Here%20we%20report%20tumor-cell-intrinsic%20chromatin%20accessibility%20patterns%20of%20treatment-na%5Cu00efve%20surgically%20resected%20PDAC%20tumors%20that%20were%20subsequently%20treated%20with%20%28Gem%29%5C%2FAbraxane%20adjuvant%20chemotherapy.%20By%20ATAC-seq%20analyses%20of%20EpCAM%2B%20PDAC%20malignant%20epithelial%20cells%20sorted%20from%2054%20freshly%20resected%20human%20tumors%2C%20we%20show%20here%20the%20discovery%20of%20a%20signature%20of%201092%20chromatin%20loci%20displaying%20differential%20accessibility%20between%20patients%20with%20disease%20free%20survival%20%28DFS%29%5Cu2009%3C%5Cu20091%20year%20and%20patients%20with%20DFS%5Cu2009%3E%5Cu20091%20year.%20Analyzing%20transcription%20factor%20%28TF%29%20binding%20motifs%20within%20these%20loci%2C%20we%20identify%20two%20TFs%20%28ZKSCAN1%20and%20HNF1b%29%20displaying%20differential%20nuclear%20localization%20between%20patients%20with%20short%20vs.%20long%20DFS.%20We%20further%20develop%20a%20chromatin%20accessibility%20microarray%20methodology%20termed%20%5Cu201cATAC-array%5Cu201d%2C%20an%20easy-to-use%20platform%20obviating%20the%20time%20and%20cost%20of%20next%20generation%20sequencing.%20Applying%20this%20methodology%20to%20the%20original%20ATAC-seq%20libraries%20as%20well%20as%20independent%20libraries%20generated%20from%20patient-derived%20organoids%2C%20we%20validate%20ATAC-array%20technology%20in%20both%20the%20original%20ATAC-seq%20cohort%20as%20well%20as%20in%20an%20independent%20validation%20cohort.%20We%20conclude%20that%20PDAC%20prognosis%20can%20be%20predicted%20by%20ATAC-array%2C%20which%20represents%20a%20low-cost%2C%20clinically%20feasible%20technology%20for%20assessing%20chromatin%20accessibility%20profiles.%22%2C%22date%22%3A%222021-05-24%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41467-021-23237-2%22%2C%22ISSN%22%3A%222041-1723%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41467-021-23237-2%22%2C%22deleted%22%3A1%2C%22collections%22%3A%5B%223XSKJF5U%22%5D%2C%22dateModified%22%3A%222021-05-25T16%3A52%3A26Z%22%7D%7D%5D%7D
Dhara, S., Chhangawala, S., Chintalapudi, H., Askan, G., Aveson, V., Massa, A. L., Zhang, L., Torres, D., Makohon-Moore, A. P., Lecomte, N., Melchor, J. P., Bermeo, J., Cardenas, A., Sinha, S., Glassman, D., Nicolle, R., Moffitt, R., Yu, K. H., Leppanen, S., … Leach, S. D. (2021). Pancreatic cancer prognosis is predicted by an ATAC-array technology for assessing chromatin accessibility. Nature Communications, 12(1), 3044. https://doi.org/10.1038/s41467-021-23237-2 Cite
